The cell cycle has been the object of extensive studies for the in vitro. [21] [22] [23] It was subsequently cloned and found to be able ation by these kinases is involved in the process of p27 proteop27 protein is expressed at higher levels in quiescent cells lysis.
in vitro. [21] [22] [23] It was subsequently cloned and found to be able intermedia with 100% penetrance. [24] [25] [26] p27 is also a target of lators as tumor suppressors provides new insights into the link oncogenic events since the adenoviral E1A 27 and the human between the cell cycle and oncogenesis. p27 is a potent inhibipapilloma viral E7 28 ation by these kinases is involved in the process of p27 proteop27 protein is expressed at higher levels in quiescent cells lysis.
than in proliferating cells. [36] [37] [38] [39] In addition, p27 abundance Keywords: cell cycle; cyclin dependent-kinase inhibitors; p27; tumor suppressors; ubiquitination increases in cells treated with cAMP, 40 tamoxifen, 41 lovastatin, 23 or rapamycin. 37 This increase is thought to be involved in the G1 block induced by these agents. Similarly, cells The eukaryotic cell division cycle is a highly ordered series undergoing differentiation have elevated levels of p27. [42] [43] [44] of events, regulated by a number of cyclin dependent kinases Interestingly, levels of p27 mRNA do not change in any of the (Cdks), each consisting of a regulatory cyclin subunit and a analyzed conditions. catalytic serine/threonine kinase subunit (for a review, see Ref.
The contrast between oscillation of p27 protein abundance 1). Several cyclin-Cdk complexes have been identified and and the constant amounts of its mRNA observed at different found to be required at different stages of the cell cycle. There cell cycle phases prompted us to determine whether p27 halfare several distinct molecular mechanisms for controlling the life was chronologically regulated by alterations of protein activity of the different Cdks: regulated synthesis and destrucstability. 45 We found that the half-life of p27 is much longer tion of the cyclin regulatory subunit; post-translational modiin quiescent than in proliferating cells. This result led us to fication of the kinase subunit by highly specific kinases and investigate the mechanisms regulating p27 degradation. 45 phosphatases, and association/dissociation with a variety of Ubiquitin is a MW 7000 protein which is covalently bound inhibitory proteins (reviewed in Ref. 2) .
through an isopeptide bond to a target protein, forming a polyBased on sequence homology and specificity of interaction ubiquitin tree (see Refs 46 and 47 for a review). This reaction with Cdks, two families of inhibitors (ckis) have been identis catalyzed by the ubiquitinating enzymes E1, E2s and E3s. ified in mammalian cells (for a review, see Ref.
3). The first E1, also called ubiquitin activating enzyme, is the first enzyme family includes p16 (also called Ink4A, Mts1, Cdkn2 and involved in protein ubiquitination. It forms a thioester bond Cdk4i 4, 5 ), p15 (also called Ink4B, Mts2 [5] [6] [7] [8] ) p18 (also called between the C-terminus of ubiquitin and an internal cysteine Ink4C and Ink6A 6, 9 ), and p19/p20 (also called Ink4D and residue. E2s, also called ubiquitin conjugating enzymes Ink6B [9] [10] [11] teasome, a multimeric protein complex, which degrades the some particular condition such as in contacted inhibited cells 38 and in cells undergoing differentiation, 53 translational target and recycles the ubiquitin. 48, 49 We tested whether the intracellular regulation of p27 abuncontrol also contributes to the regulation of p27 abundance. In conclusion, unlike other Ckis, whose abundance is primarily dance in human cells involved the ubiquitin-proteasome pathway by examining the effect of the peptide-aldehyde LLnL regulated at the level of transcription, p27 protein levels are mainly regulated by ubiquitin-mediated degradation. 45, 53 (N-acetyl-leucinyl-leucinyl-norleucinal-H), an inhibitor of the chymotryptic site on the proteasome, on cellular p27 levels. 45 Addition of LLnL induced an accumulation of p27 protein and its ubiquitinated forms of approximately Mr 70 000 and Mr 100 000. Furthermore, p27 level accumulated at the Future directions restrictive temperature in the murine ts20TG R cell line that bears a mutation in the ubiquitin-activating enzyme E1 gene.
Based on these findings, several laboratories are now continuThese results demonstrated that p27 is polyubiquitinated in ing to analyze the role of the ubiquitin-mediated proteolytic vivo.
pathway as part of the G0/G1-checkpoint control in normal An in vitro assay was then established by using purified cells and to study whether this pathway is deregulated in canrecombinant hexahistidine-tagged p27 (p27-his 6 ) as a subcer. In particular, a huge interest revolves around the role of strate for ubiquitination and rabbit reticulocyte lysate (RRL) as phosphorylation as a possible signal for p27 degradation. a source of ubiquitinating enzymes and proteasome comIt has been shown that two S. cerevisi cyclins, Cln2 54 and plexes. 45 Incubation of p27-his 6 with RRL for as little as 1 min Cln3, 55 are substrates of Ubc3 and that phosphorylation of produced ubiquitinated forms of p27. After longer incubation, these cyclins by the yeast cdk kinase, Cdc28, promotes their p27 was completely degraded. We also found that the ubiquitubiquitination. Degradation of other proteins, including the ination and degradation of p27 required ATP hydrolysis since yeast Cdk inhibitor p40 sic1 , 56 c-fos, 57 c-Jun, 58 IkB␣, 59 Rag2
60
(1) preincubation of RRL with apyrase to hydrolyze ATP preand STAT1, 61 has also been found to be stimulated by their vented the appearance of the slower migrating bands and phosphorylation. We found that p27 is a phosphoprotein and inhibited p27 proteolysis, and (2) addition of ATP-␥-S, a nonthat it is phosphorylated in vivo in both threonine and serine hydrolysable ATP analog, led to a substantial decrease in p27
(unpublished results). Phosphorylation of p27 is cell cycle proteolysis. To demonstrate that the in vitro degradation of regulated. In fact, in human osteosarcoma MG-63 39 and breast p27 requires the proteasome, we used ultracentrifugation to cancer MCF-7 cells (unpublished results), p27 phosphoryleliminate the proteasome particles from RRL. Incubation of ation reached its peak during G1, paralleling its degradation. p27 with proteasome-depleted supernatant resulted in the The temporal correlation between decrease in protein level block of p27 degradation. However, upon readdition of the and occurrence of phosphorylation suggests that p27 phosproteasome-rich pellet to the supernatant, p27 degradation phorylation may have a role in its degradation. Cdks are was completely restored.
'serine/threonine proline-directed kinases' and, because of We then tested whether addition of purified recombinant their physical association with p27, are possible candidates as human Ubcs to the RRL can alter the kinetics of the reaction.
kinases phosphorylating p27 during G1. Only two serines and These included human Ubc2, Ubc3, Ubc4, Ubc5, Ubc8, one threonine followed by a proline are present in the Ubc9, and Ubc-epi. Only Ubc2 and Ubc3 increased the rate sequence of human p27. We tested the ability of Cdk1 to of p27 turnover. We also made active site cysteine-to-serine phosphorylate p27 in vitro and found that p27 was efficiently mutations in human Ubc3, Ubc2 and Ubc4 (on cysteine 88, phosphorylated ( Figure 1a, lane 7) , almost exclusively on thre-93 and 85, respectively). The rate of p27 ubiquitination and onine ( Figure 1b, lane 2) . The presence of the two prolineits degradation was significantly decreased by the addition of directed serines in the p27 sequence prompted us to test Ubc2 and Ubc3 mutants, but not the Ubc4 mutant. Ubc3 is another 'serine/threonine proline-directed kinase', namely the human homolog of Cdc34 in S. cerevisi . Thus, our result Erk1. Interestingly, we found that Erk1 phosphorylated p27 is in agreement with the fact that in S. cerevisi , p40
Sic1 , an ( Figure 1a , lane 2), exclusively on serine (Figure 1b , lane 1) inhibitor of yeast Cdks, accumulates in ubc3/cdc34 mutant suggesting that this kinase might be involved in the in vivo cells. Deletion of the sic1 gene allows entry into S-phase, 50 phosphorylation of p27. suggesting that the G1 arrest caused by inactivation of In summary, p27 abundance is regulated by ubiquitinUbc3/Cdc34 in G1 is due to a failure to destroy p40 Sic1 . Two mediated degradation. 45, 53 Phosphorylation and degradation other yeast mutants behave exactly as cdc34 mutants: cdc53 of p27 increase in parallel when cells enter the cell cycle. 39 and cdc4. 51 Because of the functional analogy between We found that p27 is phosphorylated in vitro by the MAP p40
Sic1 and p27 and the fact that both inhibitors are ubiquitinkinase, Erk1. It is tempting to speculate that the action of ated by Cdc34/Ubc3, these data suggest that human homolmitogenic stimuli on the cell cycle is in part mediated by tarogues of Cdc53 and Cdc4 might be part of the p27-specific geted phosphorylation of p27 by Erks. This phosphorylation ubiquitinating pathway, probably acting as an E3. In fact, would, in turn, result in a signal for ubiquitin-mediated proincubation of purified p27 with Ubc2 or Ubc3 generated only teolysis of p27. Time and experiments will address the a mono-ubiquitinated form of p27, thus, it is likely that important question of p27 degradation signaling. efficient multi-ubiquitination of p27 requires additional factors that were provided by the RRL, such as an E3.
Extracts from proliferating 45 or S phase cells 52,53 contain more p27 ubiquitinating and degradation activities than Acknowledgements extracts from quiescent cells. Similarly, half-life analysis showed that p27 in proliferating cells is six-fold less stable than in quiescent cells. 45 These results explain the fact that A.A. was in part supported by an NIH Grant CA42580-11 to Raymond Erikson. MP is in part supported by an NIH Grant p27 is expressed at much higher levels in quiescent cells than in proliferating cells. In addition to protein degradation, in CA66229-02. 
